← Back to Search

Other

FODMAP diet for Irritable Bowel Syndrome

N/A
Waitlist Available
Led By Judy Nee, MD
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
aged 18-65 years at the time of screening
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial studies how diet can help symptoms of IBS-D. It looks at how a diet low in FODMAPs can reduce symptoms.

Who is the study for?
This trial is for adults aged 18-65 with Irritable Bowel Syndrome (IBS), specifically those who often have diarrhea. Participants must have normal blood and stool test results, no C diff infections or parasites, and a certain score on an IBS symptom severity scale.Check my eligibility
What is being tested?
The study is testing the effects of a Low FODMAP Diet (LFD) on patients with IBS. The LFD aims to reduce symptoms by limiting foods that are high in certain sugars which can be hard to digest and may cause gut discomfort.See study design
What are the potential side effects?
While not explicitly stated, potential side effects of the Low FODMAP Diet may include changes in diet satisfaction, nutritional deficiencies if not properly managed, and possible alterations in gut microbiota.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
colonic permeability
Secondary outcome measures
colonic immune cells
colonic microbiome

Trial Design

1Treatment groups
Experimental Treatment
Group I: FODMAP dietExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor
835 Previous Clinical Trials
13,006,491 Total Patients Enrolled
7 Trials studying Irritable Bowel Syndrome
685 Patients Enrolled for Irritable Bowel Syndrome
University of MichiganOTHER
1,782 Previous Clinical Trials
6,364,667 Total Patients Enrolled
12 Trials studying Irritable Bowel Syndrome
912 Patients Enrolled for Irritable Bowel Syndrome
Judy Nee, MDPrincipal InvestigatorBeth Israel Deaconess Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research initiative accepting new participants?

"The information on clinicaltrials.gov specifies that this trial is not presently seeking patients as it was last modified in August of 2020. Despite this, there are currently 1,491 studies recruiting which may be of interest."

Answered by AI

Who is eligible to take part in this research endeavor?

"In order to participate in this trial, participants must be 18-65 years old and suffer from Irritable Bowel Syndrome. This medical experiment is currently recruiting a total of 40 subjects."

Answered by AI

Is the age threshold for this research exceeding 85 years?

"To be considered suitable for this trial, individuals must have an age between 18 and 65. However, those under the legal drinking age or above retirement can still participate in the numerous clinical trials available to them; 384 separate studies are open to minors while 1,055 cater specifically to seniors."

Answered by AI
~7 spots leftby Mar 2025